Adel Kardosh Selected Research

Adel Kardosh Research Topics

Disease

17	Neoplasms (Cancer) 06/2022 - 12/2003
5	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 05/2020
5	Glioblastoma (Glioblastoma Multiforme) 05/2008 - 01/2004
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 05/2008
3	Neoplasm Metastasis (Metastasis) 03/2021 - 12/2019
3	Glioma (Gliomas) 11/2007 - 04/2006
2	Adenocarcinoma 06/2022 - 01/2022
2	Lymphoma (Lymphomas) 11/2018 - 11/2006
2	Multiple Myeloma 06/2009 - 12/2005
1	Margins of Excision 03/2021
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2021
1	Rectal Neoplasms (Rectal Cancer) 12/2019
1	Bites and Stings (Sting) 11/2018
1	Hypoxia (Hypoxemia) 09/2007
1	Acquired Immunodeficiency Syndrome (AIDS) 11/2006
1	Burkitt Lymphoma (Burkitt's Lymphoma) 05/2005
1	Colorectal Neoplasms (Colorectal Cancer) 01/2004
1	Carcinoma (Carcinomatosis) 12/2003
1	Carcinogenesis 12/2003
1	Ovarian Neoplasms (Ovarian Cancer) 12/2003

Drug/Important Bio-Agent (IBA)

9	Celecoxib (Celebrex)FDA Link 05/2008 - 01/2004
7	Pharmaceutical PreparationsIBA 03/2010 - 05/2005
6	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 02/2008 - 01/2004
4	2,5-dimethylcelecoxibIBA 03/2010 - 04/2007
4	Proteins (Proteins, Gene)FDA Link 11/2007 - 11/2006
3	Endoplasmic Reticulum Chaperone BiPIBA 02/2008 - 04/2007
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 09/2007 - 05/2005
3	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 11/2006 - 01/2004
2	Yttrium-90IBA 09/2020 - 05/2020
2	Proteasome Endopeptidase Complex (Proteasome)IBA 06/2009 - 11/2007
2	Caspase 7IBA 06/2009 - 05/2008
2	Bortezomib (Velcade)FDA Link 06/2009 - 02/2008
2	Small Interfering RNA (siRNA)IBA 02/2008 - 04/2007
2	Apoptosis Regulatory ProteinsIBA 09/2007 - 05/2006
2	SurvivinIBA 09/2007 - 05/2006
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 11/2006 - 01/2004
1	Sorafenib (BAY 43-9006)FDA Link 01/2022
1	pembrolizumabIBA 01/2022
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2021
1	Radioisotopes (Radionuclides)IBA 01/2021
1	Peptide Receptors (Peptide Receptor)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 12/2019
1	Immunomodulating AgentsIBA 11/2018
1	AntibodiesIBA 11/2018
1	Biological FactorsIBA 01/2018
1	Interleukin-8 (Interleukin 8)IBA 03/2010
1	Endothelin-1 (Endothelin 1)IBA 03/2010
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2010
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 06/2009
1	catechol (pyrocatechol)IBA 06/2009
1	Proteasome InhibitorsIBA 06/2009
1	TeaIBA 06/2009
1	PolyphenolsIBA 06/2009
1	Drug CombinationsIBA 02/2008
1	Human immunodeficiency virus 1 p16 proteaseIBA 11/2007
1	Protease Inhibitors (Protease Inhibitor)IBA 11/2007
1	Nelfinavir (Viracept)FDA Link 11/2007
1	Atazanavir Sulfate (Reyataz)FDA Link 11/2007
1	Glucose (Dextrose)FDA LinkGeneric 09/2007
1	cobaltous chloride (cobalt(II)chloride)IBA 09/2007
1	beta-Galactosidase (Lactaid)IBA 04/2007
1	CalciumIBA 04/2007
1	EnzymesIBA 11/2006
1	Irinotecan (Camptosar)FDA LinkGeneric 05/2006
1	hypericinIBA 04/2006
1	Temozolomide (Temodar)FDA LinkGeneric 04/2006
1	Tamoxifen FDA LinkGeneric 04/2006
1	Cyclin AIBA 01/2004
1	Cyclin BIBA 01/2004
1	Progesterone FDA LinkGeneric 12/2003
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 12/2003
1	Tumor Biomarkers (Tumor Markers)IBA 12/2003
1	CA-125 Antigen (CA 125 Antigen)IBA 12/2003
1	Hormones (Hormone)IBA 12/2003

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 06/2022 - 05/2006
7	Therapeutics 01/2021 - 04/2006
4	Neoadjuvant Therapy 06/2022 - 12/2019
1	Chemoradiotherapy 06/2022
1	Hepatectomy 01/2021
1	Salvage Therapy 01/2021
1	Immunotherapy 11/2018
1	Radiotherapy 11/2006